Razor Labs Logo

Razor Labs

RZR.TA

(0.5)
Stock Price

463,70 ILA

-16.27% ROA

-27.8% ROE

-5.14x PER

Market Cap.

54.967.920,00 ILA

55.73% DER

0% Yield

-562.2% NPM

Razor Labs Stock Analysis

Razor Labs Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Razor Labs Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's PBV ratio (1.62x) indicates a justifiable valuation, presenting a compelling choice for investors seeking reasonable returns.

2 DER

The stock maintains a fair debt to equity ratio (54%), indicating a reasonable balance between the money it owes and the ownership it possesses.

3 ROE

Negative ROE (-23.19%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-14.58%) indicates that it's not effectively utilizing its assets to generate profits, making it a less favorable option to invest and earn consistent returns.

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

Over the past five years, this company's net profit has failed to exhibit any growth, indicating a stagnant financial performance and making it a less favorable choice for potential investors.

7 Assets Growth

Company's revenue has remained stagnant over the past three years, indicating a lack of growth and making it a less favorable option.

8 Graham Number

The company's Graham number suggests that its stock price is overestimated, implying that it may not be a promising investment opportunity.

9 Dividend Growth

The company's dividend growth has remained flat for the past three years, offering no indication of improved returns and making it a less advantageous investment opportunity.

10 Dividend

Investors should note the absence of dividends from the company in the last three years, indicating potential financial challenges.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (-435), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Razor Labs Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Razor Labs Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Sell
3 RSI Hold
4 Stoch RSI Sell

Razor Labs Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Razor Labs Revenue
Year Revenue Growth
2020 22.299.000
2021 14.198.000 -57.06%
2022 4.496.000 -215.79%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Razor Labs Research and Development Expenses
Year Research and Development Expenses Growth
2020 4.961.000
2021 18.525.000 73.22%
2022 10.652.000 -73.91%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Razor Labs General and Administrative Expenses
Year General and Administrative Expenses Growth
2020 625.000
2021 3.385.000 81.54%
2022 -8.552.000 139.58%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Razor Labs EBITDA
Year EBITDA Growth
2020 1.496.000
2021 -40.954.000 103.65%
2022 -13.876.000 -195.14%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Razor Labs Gross Profit
Year Gross Profit Growth
2020 11.229.000
2021 1.908.000 -488.52%
2022 756.000 -152.38%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Razor Labs Net Profit
Year Net Profit Growth
2020 -7.000
2021 -41.570.000 99.98%
2022 -18.372.000 -126.27%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Razor Labs Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2020 0
2021 -1 100%
2022 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Razor Labs Free Cashflow
Year Free Cashflow Growth
2020 1.274.000
2021 -36.433.000 103.5%
2022 -3.850.000 -846.31%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Razor Labs Operating Cashflow
Year Operating Cashflow Growth
2020 1.528.000
2021 -32.785.000 104.66%
2022 -3.806.000 -761.4%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Razor Labs Capital Expenditure
Year Capital Expenditure Growth
2020 254.000
2021 3.648.000 93.04%
2022 44.000 -8190.91%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Razor Labs Equity
Year Equity Growth
2020 4.611.000
2021 69.880.000 93.4%
2022 42.805.000 -63.25%
2023 34.390.000 -24.47%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Razor Labs Assets
Year Assets Growth
2020 23.476.000
2021 101.217.000 76.81%
2022 71.299.000 -41.96%
2023 63.893.000 -11.59%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Razor Labs Liabilities
Year Liabilities Growth
2020 18.865.000
2021 31.337.000 39.8%
2022 28.494.000 -9.98%
2023 29.503.000 3.42%

Razor Labs Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.05
Net Income per Share
-0.27
Price to Earning Ratio
-5.14x
Price To Sales Ratio
29.73x
POCF Ratio
-5.65
PFCF Ratio
-5.77
Price to Book Ratio
1.56
EV to Sales
19.08
EV Over EBITDA
-4.29
EV to Operating CashFlow
-3.73
EV to FreeCashFlow
-3.71
Earnings Yield
-0.19
FreeCashFlow Yield
-0.17
Market Cap
0,05 Bil.
Enterprise Value
0,04 Bil.
Graham Number
2.35
Graham NetNet
0.25

Income Statement Metrics

Net Income per Share
-0.27
Income Quality
0.91
ROE
-0.25
Return On Assets
-0.13
Return On Capital Employed
-0.16
Net Income per EBT
1.01
EBT Per Ebit
1.01
Ebit per Revenue
-5.52
Effective Tax Rate
-0.01

Margins

Sales, General, & Administrative to Revenue
-0.54
Research & Developement to Revenue
3.15
Stock Based Compensation to Revenue
0.1
Gross Profit Margin
0.15
Operating Profit Margin
-5.52
Pretax Profit Margin
-5.59
Net Profit Margin
-5.62

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-0.25
Free CashFlow per Share
-0.25
Capex to Operating CashFlow
0.01
Capex to Revenue
-0.03
Capex to Depreciation
-0.04
Return on Invested Capital
-0.14
Return on Tangible Assets
-0.16
Days Sales Outstanding
0
Days Payables Outstanding
238.77
Days of Inventory on Hand
0
Receivables Turnover
0
Payables Turnover
1.53
Inventory Turnover
0
Capex per Share
-0

Balance Sheet

Cash per Share
1,02
Book Value per Share
0,90
Tangible Book Value per Share
0.9
Shareholders Equity per Share
0.9
Interest Debt per Share
0.51
Debt to Equity
0.56
Debt to Assets
0.3
Net Debt to EBITDA
2.39
Current Ratio
4.5
Tangible Asset Value
0,03 Bil.
Net Current Asset Value
0,01 Bil.
Invested Capital
0.56
Working Capital
0,03 Bil.
Intangibles to Total Assets
0
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
0
Debt to Market Cap
0.35

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Razor Labs Dividends
Year Dividends Growth

Razor Labs Profile

About Razor Labs

Razor Labs operates in the artificial intelligence (AI) industry in Israel. It offers DataMind, an industrial optimization platform to take manufacturing process into a virtual world; and AI pipeline, a video analytics platform to chain together various AI applications into one solution that fit corporate objectives. The company is based in Tel Aviv, Israel.

CEO
Mr. Raz Roditti
Employee
27
Address
Derech Menachem Begin 150
Tel Aviv,

Razor Labs Executives & BODs

Razor Labs Executives & BODs
# Name Age
1 Mr. Edu Meytal
Chief Business Officer
70
2 Maor Amsellem
Vice President of Finance
70
3 Mr. Raz Roditti
Co-Founder, Chief Executive Officer & Chairman of the Board
70
4 Liron Gerbi
Vice President of Human Resources
70
5 Mr. Michael Zolotov
Co-Founder, Chief Technology Officer & Director
70
6 Mr. Tomer Srulevich
Chief Business Officer
70
7 Mr. Ido Rozenberg
Co-Founder & Director
70
8 Mr. Asaf Eden
Vice President of Product
70
9 Liel Anisenko
Director of Marketing
70
10 Nirit Chen
Head of Delivery
70

Razor Labs Competitors

InterCure Ltd. Logo
InterCure Ltd.

INCR.TA

(2.2)
Bonus BioGroup Ltd. Logo
Bonus BioGroup Ltd.

BONS.TA

(1.0)
Gencell Ltd Logo
Gencell Ltd

GNCL.TA

(1.2)
Aura Smart Air Ltd Logo
Aura Smart Air Ltd

AUSA.TA

(0.0)